However, Sundsmo said that showing the battery as an "intermediate product" to a stable place and reprogramming the water level there will be used for treatment and basic research; However, he admits that the word "intermediate product" is "loose and slightly authorized". "Pluripotency and proliferation are separate," he said. "We still don't understand." Sundsmo said that they are waiting: waiting for the results of teratoma experiments-where the battery is allowed to develop and where it is active-to confirm whether the battery is really pluripotent.
Edenhofer, a stem cell expert at the University of Bonn in Germany, called the technology "attractive and promising". But his own experiments show that 10 billion particles are "toxic and inefficient". Other groups have also found that nanotubes can damage batteries and make it difficult to distribute their goods. Gaithersburg of the National Institute of Standards and Technology in Maryland nodded, saying that the ability of nanotubes to make virus-infected nucleic acid batteries "depends on how the materials are prepared, how they enter the battery, how they disperse inside the solution and the specific mechanism of the entrance road".
Some scientists look forward to PrimeGen's battery. First, Peter Donovan, a stem cell expert at the University of California, Irvine and a member of PrimeGen's advisory board, said, "They look really good. But what I really like to read is the published newspaper. "
Because PrimeGen announced its ruling meeting among investors on February 26th, scientists who had the most contact naturally expressed doubts and were unwilling to be published in Science. Rudolph Genese of Massachusetts Institute of Stem Cell Pioneer Technology, another advisory board member of PrimeGen Science in Cambridge, told Nature that he left Bana a few days later, but he did not provide any reasons. PrimeGen doesn't seem to know the change of Jaenisch when he was born in contact.
Sundsmo said that since the company has submitted a patent application, they decided to publish the results and stop publishing forward. He said: "conceptually, this is a very common observation and can be easily repeated."
Two years ago, PrimeGen also published experimental results describing pluripotent stem cells from semen precursor batteries. Automatic gearbox time PrimeGen told nature that they would publish a paper, but not already. Sundsmo said that the science behind the paper tendon is already at the core of the company's technology, and it must be expressed in a new form because of the internal inconsistency in the experiment. Sundsmo said that half of the companies have been fired and the newspapers have been accepted for publication.